Adaptam Therapeutics vs Hexagon Bio
Adaptam Therapeutics vs Hexagon Bio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptam Therapeutics is on 53/100 and Hexagon Bio on 57/100.
Where each one leads
Adaptam Therapeutics
- agent readiness: 42/100 against 21/100
Hexagon Bio
- our overall score: 57/100 against 53/100
- domain rating: 28/100 against 4/100
- headcount: 70 against 6
- funding raised: $100M against $4.7M
- LinkedIn following: 6,777 against 604
At a glance
| Measure | Adaptam Therapeutics | Hexagon Bio |
|---|---|---|
| What it is | Developing novel therapeutics for rare genetic diseases with a focus on protein degradation. | Developing novel therapeutics by understanding the complex interplay of biological systems. |
| Category | Biotech, Drug Discovery, Genomics, Rare Diseases | Biotech, Drug Discovery, Genomics, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2021 | 2019 |
| Headquarters | Cambridge, United States | Menlo Park, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptam Therapeutics | Hexagon Bio |
|---|---|---|
| Employees | 6 | 70 |
| Total funding | $4.7M | $100M |
| Latest round | Seed | Series B |
| LinkedIn followers | 604 | 6,777 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptam Therapeutics | Hexagon Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 57/100 |
| Traction | 33/100 | 59/100 |
| Team | Not published | 40/100 |
| Search visibility | 5/100 | 34/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 4/100 | 28/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptam Therapeutics | Hexagon Bio |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
Adaptam Therapeutics vs Hexagon Bio: common questions
Which is better, Adaptam Therapeutics or Hexagon Bio?
On our 0-100 score Hexagon Bio rates higher (57/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Adaptam Therapeutics and Hexagon Bio compare on the numbers?
Adaptam Therapeutics leads on agent readiness (42/100 against 21/100). Hexagon Bio leads on our overall score (57/100 against 53/100), domain rating (28/100 against 4/100), headcount (70 against 6), funding raised ($100M against $4.7M), LinkedIn following (6,777 against 604).
Read the full Adaptam Therapeutics review and pricing or the Hexagon Bio review and pricing. You can also browse other Adaptam Therapeutics alternatives we track.